143.40 USD
▼-4.38-2.96%
盘后 157.41 0.00%
2026-09-15
市值
$9.28B
市盈率
117.43
EPS
1.22
股息率
—
52 周区间
57.90 – 160.81
成交量
604.91K
Beta
1.79
目标价
174.69
52W 低 57.9052W 高 160.81
价格走势
公司简介
Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class or...